PTC Therapeutics, Inc.  announced today that it has withdrawn the New Drug Application (NDA) resubmission for Translarnatm ...

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it has withdrawn the New Drug Application (NDA) resubmission for Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne ...

Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against uniQure N.V. ("uniQure" or the "Company") on behalf of investors who ...

India's biopharmaceutical excipients market is set for significant growth driven by the rise of biologics, government support like the PLI program, and growing outsourcing trends. Opportunities lie in ...

Ingalls Shipbuilding division awarded $95,700 in STEM grants to 22 schools and educational organizations across south ...

As well as our regular news and photos from schools across Wrexham and Flintshire, we have a round-up of events and achievements in today's School Report.

The Government gives utmost priority to the safety, security and empowerment of girls in the country. To this end, the Government has adopted multi-pronged approach to address the educational, ...

Eli Lilly will shell out $2.4 billion to acquire genetic medicine developer Orna Therapeutics and has committed up to $8.85 billion to launch a seventh collaboration with Innovent Biologics. Both ...

Discusses Positive Phase 3 PROPEL 3 Results for Infigratinib in Children With Achondroplasia February 12, 2026 8:00 ...

The defense starts its arguments on Tuesday in the Austin Thompson case. Thompson, now 18, was 15 at the time he opened fire in Raleigh's Hedingham neighborhood and killed five people.

Amgen (NASDAQ:AMGN) today announced the European Commission (EC) has approved UPLIZNA® (inebilizumab) as an add-on treatment to ...

The teacher was halfway through explaining a lesson when she suddenly stopped. A piece of chalk slipped from her fingers and clattered to the floor as her eyes fixed on a child sitting in the corner ...